Clin2
NCT06907121Possibly a fitNot yet recruiting

Growth hormone and platelet-rich plasma for knee or ankle arthritis

Arthritis AnkleArthritis Knee

Part of Bones, joints & muscles clinical trials.

This study tests whether combining growth hormone with platelet-rich plasma (a substance from your own blood) can improve joint health in people with knee or ankle arthritis. It aims to find a new way to reduce pain and improve function when standard treatments haven't worked.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
192 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have arthritis or cartilage damage in your knee or ankle that hasn't improved with usual care from your doctor.
  • An MRI or X-ray taken within the last 6 months shows moderate cartilage damage (grade 1–3), not severe bone-on-bone arthritis.
  • You are between 18 and 70 years old.
  • You are not pregnant or breastfeeding and, if you could become pregnant, you agree to use birth control during the study.
  • You are willing to visit the clinic for all follow-up appointments.
  • You do not have cancer, active infections at the injection site, or certain metabolic bone disorders.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06932614Recruiting
Growth factor vs PRP for knee arthritis

This trial compares two injections—a special growth factor treatment and a platelet-rich plasma (PRP) injection—to see which works better for knee osteoarthritis. It aims to help people with mild to moderate knee arthritis who have had pain for at least 3 months.

Taipei
NCT07339137Recruiting
PRP injections for chronic knee osteoarthritis

This trial tests if platelet-rich plasma (PRP) injections into and around the knee joint can reduce pain and improve function for people with moderate knee osteoarthritis who haven't gotten relief from other treatments.

Ankara, Çankaya
NCT05039463Recruiting
Platelet-Rich Plasma and Hyaluronic Acid for Knee Arthritis

This trial tests whether combining two types of injections—platelet-rich plasma (a concentration of healing cells from your own blood) and hyaluronic acid (a natural lubricant)—can reduce knee osteoarthritis pain and improve function over one year. You're eligible if you've already received or are about to receive these injections at Amiens University Hospital.

Amiens
NCT06483269Recruiting
Platelet-rich plasma injection for knee arthritis in young athletes

This trial tests using your own platelet-rich plasma (PRP), made from a blood sample, as an injection to treat knee osteoarthritis in active young adults. The goal is to see if it reduces pain and helps you stay active.

Bologna
NCT06685120Recruiting
PRP and hyaluronic acid for knee osteoarthritis

This study tests a combination of platelet-rich plasma (PRP) and hyaluronic acid injections for knee osteoarthritis. It aims to see if these injections together can reduce pain and improve function better than standard treatments.

Bologna
NCT07784907Recruiting
Platelet-rich plasma and hyaluronic acid for knee arthritis

This trial tests whether a combination of platelet-rich plasma (a concentrate from your own blood) and hyaluronic acid (a joint lubricant) helps reduce pain and improve function in people with knee arthritis. You may be eligible if you have moderate knee pain but your other knee is relatively pain-free.

Chełm, Lublin Voivodeship

Hear when a new Arthritis Knee trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.